Report: COVID-19 may be catalyst for innovative partnerships
![doctor leading a team meeting](/sites/default/files/styles/900x400/public/2019-11/stock-doctor-meeting-consult-900.jpg?itok=2Ac5VYKi)
The COVID-19 pandemic has confirmed the strategic rationale underlying many hospital and health system mergers and acquisitions and may be acting as a catalyst for innovative strategic partnerships and tactical transactions, according to a new report by management consultancy KaufmanHall.
The report looks at key M&A trends as the pandemic compels health care organizations to focus on core business strengths, build partnerships and strengthen intellectual capital resources.
With respect to building partnerships, it says the COVID-19 crisis “should encourage healthcare leaders, federal and state legislators, and government agencies to reevaluate gaps in the nation’s healthcare infrastructure and recognize the value of building new partnerships to support a healthcare system that can provide high-quality care, accessible to all.”